Comment Period Extended to 3/23/2015 for Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials

Clinical Investigation of Galnobax® for the Treatment of Diabetic Foot Ulcers

This study is currently recruiting participants. (see Contacts and Locations)
Verified February 2014 by Novalead Pharma Private Limited
Information provided by (Responsible Party):
Novalead Pharma Private Limited Identifier:
First received: April 28, 2010
Last updated: May 27, 2014
Last verified: February 2014
No Study Results Posted on for this Study
  Study Status: This study is currently recruiting participants.
  Estimated Study Completion Date: April 2015
  Estimated Primary Completion Date: December 2014 (Final data collection date for primary outcome measure)